Apollo Hospitals Enterprise Limited vs Procter & Gamble Health Limited

A side-by-side comparison of Apollo Hospitals Enterprise Limited (APOLLOHOSP) and Procter & Gamble Health Limited (PGHL) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Procter & Gamble Health Limited leads APOLLOHOSP vs PGHL on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation13
  • Profitability04
  • Growth20
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

PGHL takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

58.43
P/E ratio
26.40
13.46
P/B ratio
17.16
0.22%
Dividend yield
3.78%
₹135.04
EPS
₹196.94

Profitability

PGHL takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

20.48%
Return on equity
62.32%
17.31%
Return on capital
84.37%
14.94%
EBITDA margin
32.43%
7.94%
Net margin
23.22%

Growth

APOLLOHOSP takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
4.61%
33.35%
Profit CAGR (3Y)
12.60%

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.14L Cr
Market cap
₹8,641 Cr
₹25,229 Cr
Revenue
₹1,408 Cr
₹2,003 Cr
Net profit
₹327 Cr
0.90
Debt / equity
0.02
Apollo Hospitals Enterprise Limited
  • + ["Company has delivered good profit growth of 71.0% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
  • − ["Stock is trading at 11.97 times its book value"]
Procter & Gamble Health Limited
  • + ["Company has been maintaining a healthy dividend payout of 104.1%", "Company is almost debt free."]
  • − ["Stock is trading at 16.46 times its book value"]
Apollo Hospitals Enterprise Limited full analysis Procter & Gamble Health Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.